ADULT T-CELL LEUKEMIA/LYMPHOMA
Clinical trials for ADULT T-CELL LEUKEMIA/LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ADULT T-CELL LEUKEMIA/LYMPHOMA trials appear
Sign up with your email to follow new studies for ADULT T-CELL LEUKEMIA/LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for rare blood cancer
Disease control CompletedThis study tested a drug called belinostat combined with zidovudine (AZT) as a follow-up treatment for people with adult T-cell leukemia-lymphoma (ATLL), a rare and aggressive blood cancer. The goal was to see if the combination could make cancer cells disappear from the blood. T…
Matched conditions: ADULT T-CELL LEUKEMIA/LYMPHOMA
Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control
Last updated May 17, 2026 05:33 UTC
-
New hope for Hard-to-Treat lymphoma? drug shows promise in small study
Disease control CompletedThis study tested a drug called brentuximab vedotin in 23 people with a rare type of T-cell lymphoma that had stopped responding to or returned after prior chemotherapy. The drug targets a marker called CD30, even when levels are very low. The main goal was to see if the drug cou…
Matched conditions: ADULT T-CELL LEUKEMIA/LYMPHOMA
Phase: PHASE2 • Sponsor: Deepa Jagadeesh • Aim: Disease control
Last updated May 12, 2026 13:43 UTC